Acquired dysfibrinogenemia secondary to multiple myeloma
Jazyk angličtina Země Švýcarsko Médium print-electronic
Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem
PubMed
18841003
DOI
10.1159/000160182
PII: 000160182
Knihovny.cz E-zdroje
- MeSH
- afibrinogenemie etiologie terapie MeSH
- fibrin chemie MeSH
- fibrinogen metabolismus MeSH
- lidé MeSH
- mikroskopie elektronová rastrovací MeSH
- mnohočetný myelom komplikace MeSH
- paraproteiny analýza metabolismus MeSH
- peptidové fragmenty metabolismus MeSH
- senioři MeSH
- vyšetření krevní srážlivosti MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- práce podpořená grantem MeSH
- Názvy látek
- fibrin MeSH
- fibrinogen gamma (151-411) MeSH Prohlížeč
- fibrinogen MeSH
- paraproteiny MeSH
- peptidové fragmenty MeSH
Abnormal coagulation properties indicative of a dysfibrinogen were found in the plasma of a 72-year-old male with multiple myeloma (IgGkappa, stage IIIA). The patient had high paraprotein concentration (85.75 g/l) and prolonged thrombin time (76.8 s), activated partial thromboplastin time (39.5 s), prothrombin time (23.5 s) and reptilase time (72.0 s). The fibrinogen level was increased. The fibrin polymerization induced by both thrombin and reptilase was impaired. Scanning electron microscopy revealed abnormal clot morphology. After six months of treatment, the paraprotein level decreased (19.48 g/l) and coagulation normalized as well as fibrin polymerization and fibrin clot morphology. It was found that the paraprotein interacts with the gamma-chain of fibrinogen. Acquired dysfibrinogenemia associated with multiple myeloma was diagnosed in the 72-year-old patient.
Citace poskytuje Crossref.org